한글목차

세계의 히알루로니다제 시장은 2024년에 11억 1,000만 달러로 평가되었으며, 2030년까지 CAGR 8.91%로 성장하여 18억 5,000만 달러에 달할 것으로 예측됩니다.

히알루로니다제는 글리코사미노글리칸인 히알루론산을 분해하는 효소로, 이를 통해 조직의 점도를 낮추고 조직 내 물질의 확산을 촉진합니다. 세계 히알루로니다제 시장은 특히 종양학 및 안과학 분야에서 약물전달을 개선해야 하는 질환의 유병률 증가와 최소침습적 미용 시술에 대한 수요 증가에 힘입어 성장하고 있습니다.

주요 시장 촉진요인

세계 히알루로니다제 시장은 미용 및 피부과 치료에 대한 수요 급증의 영향을 크게 받고 있습니다. 이 효소는 빠르게 확대되고 있는 미용 의료 분야에서 히알루론산 필러의 합병증을 교정하고, 환자의 안전을 보장하며, 치료 결과를 향상시키는 데 매우 중요합니다.

주요 시장 과제

세계 히알루로니다제 시장은 합성 히알루로니다제 변종과 관련된 높은 제조 비용이라는 중대한 도전에 직면해 있습니다. 신규 생물학적 제제의 개발 및 시장 출시에는 막대한 자금 투자가 필요합니다.

주요 시장 동향

재조합 및 합성 히알루로니다제 제제로의 전환은 동물 유래 제제에 비해 순도와 균일성이 향상되고 면역원성을 감소시킬 수 있다는 점에서 세계 시장에서 중요한 트렌드가 되고 있습니다. 이러한 첨단 제제는 보다 예측 가능한 치료 결과와 폭넓은 임상 적용을 가능하게 합니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 히알루로니다제 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 종류별(동물 유래 히알루로니다제, 합성 히알루로니다제)
  • 용도별(피부과, 화학요법, 안과, 성형외과, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 히알루로니다제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 히알루로니다제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 히알루로니다제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 히알루로니다제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 히알루로니다제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 히알루로니다제 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Amphastar Pharmaceuticals, Inc.
• PrimaPharma, Inc.,
• Halozyme, Inc.
• Bausch & Lomb Incorporated
• The Cooper Companies Inc.,
• Sun Pharmaceutical Industries Ltd.
• STEMCELL Technologies Inc.
• Shreya Life Sciences Pvt. Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Hyaluronidase Market, valued at USD 1.11 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 1.85 Billion by 2030. Hyaluronidase is an enzyme that degrades hyaluronic acid, a glycosaminoglycan, thereby reducing tissue viscosity and enhancing the diffusion of substances through tissues. The global hyaluronidase market is primarily driven by the increasing demand for minimally invasive cosmetic procedures and a rising prevalence of conditions necessitating improved drug delivery, particularly in oncology and ophthalmology.

Key Market Drivers

The global hyaluronidase market is significantly influenced by the surging demand for aesthetic and dermatological procedures. This enzyme is crucial for correcting hyaluronic acid filler complications, ensuring patient safety and enhancing treatment outcomes in a rapidly expanding cosmetic landscape. For instance, according to the International Society of Aesthetic Plastic Surgery, in July 2025, their 2024 Global Survey on Aesthetic/Cosmetic Procedures reported that hyaluronic acid procedures grew by 5.2% to 6.3 million procedures worldwide in 2024, highlighting the increasing need for hyaluronidase for both primary procedures and complication management.

Key Market Challenges

The global hyaluronidase market encounters a significant challenging factor in the high production costs associated with synthetic hyaluronidase variants. Developing and bringing novel biological entities to market involves substantial financial investment. According to the European Federation of Pharmaceutical Industries and Associations, the cost of researching and developing a new chemical or biological entity was estimated at €3,130 million in 2022. This considerable outlay for research and development directly influences the final market price of synthetic hyaluronidase products, making them less accessible in various healthcare settings.

Key Market Trends

The shift towards recombinant and synthetic hyaluronidase formulations represents a significant trend in the global market, driven by enhanced purity, consistency, and reduced immunogenicity compared to animal-derived counterparts. These advanced formulations allow for more predictable outcomes and broader clinical utility. According to the FDA, in 2024, biologics accounted for 32% of all new drug approvals, marking a notable increase from the 28% average over the prior six years, underscoring the growing importance of such products in the pharmaceutical landscape.

Key Market Players

• Amphastar Pharmaceuticals, Inc.
• PrimaPharma, Inc.,
• Halozyme, Inc.
• Bausch & Lomb Incorporated
• The Cooper Companies Inc.,
• Sun Pharmaceutical Industries Ltd.
• STEMCELL Technologies Inc.
• Shreya Life Sciences Pvt. Ltd.

Report Scope:

In this report, the Global Hyaluronidase Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hyaluronidase Market, By Type:

• Animal Derived Hyaluronidase
• Synthetic Hyaluronidase

Hyaluronidase Market, By Application:

• Dermatology
• Chemotherapy
• Ophthalmology
• Plastic Surgery
• Others

Hyaluronidase Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hyaluronidase Market.

Available Customizations:

Global Hyaluronidase Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hyaluronidase Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Animal Derived Hyaluronidase, Synthetic Hyaluronidase)
  • 5.2.2. By Application (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Hyaluronidase Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hyaluronidase Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Hyaluronidase Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Hyaluronidase Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Hyaluronidase Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hyaluronidase Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Hyaluronidase Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Hyaluronidase Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Hyaluronidase Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Hyaluronidase Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Hyaluronidase Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hyaluronidase Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Hyaluronidase Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Hyaluronidase Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Hyaluronidase Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Hyaluronidase Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Hyaluronidase Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hyaluronidase Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Hyaluronidase Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Hyaluronidase Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Hyaluronidase Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hyaluronidase Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Hyaluronidase Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Hyaluronidase Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hyaluronidase Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Amphastar Pharmaceuticals, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. PrimaPharma, Inc.,
• 15.3. Halozyme, Inc.
• 15.4. Bausch & Lomb Incorporated
• 15.5. The Cooper Companies Inc.,
• 15.6. Sun Pharmaceutical Industries Ltd.
• 15.7. STEMCELL Technologies Inc.
• 15.8. Shreya Life Sciences Pvt. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer